Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Aug;300(2):290-300.
doi: 10.1148/radiol.2021204581. Epub 2021 May 18.

Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016

Affiliations
Observational Study

Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016

Janie M Lee et al. Radiology. 2021 Aug.

Abstract

Background Since 2007, digital mammography and digital breast tomosynthesis (DBT) replaced screen-film mammography. Whether these technologic advances have improved diagnostic performance has, to the knowledge of the authors, not yet been established. Purpose To evaluate the performance and outcomes of surveillance mammography (digital mammography and DBT) performed from 2007 to 2016 in women with a personal history of breast cancer and compare with data from 1996 to 2007 and the performance of digital mammography screening benchmarks. Materials and Methods In this observational cohort study, five Breast Cancer Surveillance Consortium registries provided prospectively collected mammography data linked with tumor registry and pathologic outcomes. This study identified asymptomatic women with American Joint Committee on Cancer anatomic stages 0-III primary breast cancer who underwent surveillance mammography from 2007 to 2016. The primary outcome was a second breast cancer diagnosis within 1 year of mammography. Performance measures included the recall rate, cancer detection rate, interval cancer rate, positive predictive value of biopsy recommendation, sensitivity, and specificity. Results Among 32 331 women who underwent 117 971 surveillance mammographic examinations (112 269 digital mammographic examinations and 5702 DBT examinations), the mean age at initial diagnosis was 59 years ± 12 (standard deviation). Of 1418 second breast cancers diagnosed, 998 were surveillance-detected cancers and 420 were interval cancers. The recall rate was 8.8% (10 365 of 117 971; 95% CI: 8.6%, 9.0%), the cancer detection rate was 8.5 per 1000 examinations (998 of 117 971; 95% CI: 8.0, 9.0), the interval cancer rate was 3.6 per 1000 examinations (420 of 117 971; 95% CI: 3.2, 3.9), the positive predictive value of biopsy recommendation was 31.0% (998 of 3220; 95% CI: 29.4%, 32.7%), the sensitivity was 70.4% (998 of 1418; 95% CI: 67.9%, 72.7%), and the specificity was 98.1% (114 331 of 116 553; 95% CI: 98.0%, 98.2%). Compared with previously published studies, interval cancer rate was comparable with rates from 1996 to 2007 in women with a personal history of breast cancer and was higher than the published digital mammography screening benchmarks. Conclusion In transitioning from screen-film to digital mammography and digital breast tomosynthesis, surveillance mammography performance demonstrated minimal improvement over time and remained inferior to the performance of screening mammography benchmarks. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Moy and Gao in this issue.

PubMed Disclaimer

Conflict of interest statement

Disclosures of Conflicts of Interest: J.M.L. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed grant from GE Healthcare. Other relationships: disclosed no relevant relationships. L.E.I. disclosed no relevant relationships. K.J.W. disclosed no relevant relationships. E.B. disclosed no relevant relationships. J.M.S. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed money to author for consultancies from Nektar Therapeutics, Genomic Health, Daiichi Sankyo; grants/grants pending from Pfizer, Nektar Therapeutics, Merck, Myriad Pharmaceuticals, Cascadian Therapeutics, Minerva Biotechnologies, Genentech, Seattle Genetics, Novartis. Other relationships: disclosed no relevant relationships. K.K. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed unpaid consultant to Grail for STRIVE study. Other relationships: disclosed no relevant relationships. D.L.M. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed royalties from Elsevier. Other relationships: disclosed no relevant relationships. K.P.L. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: disclosed grants/grants pending from GE Healthcare. Other relationships: disclosed no relevant relationships. A.N.A.T. disclosed no relevant relationships. N.K.S. disclosed no relevant relationships. N.H. disclosed no relevant relationships. T.O. disclosed no relevant relationships. D.S.M.B. Activities related to the present article: disclosed fees for participation in review activities from Women Informed to Screen Depending on Measures of Risk Data Safety and Monitoring Board. Activities not related to the present article: disclosed no relevant relationships. Other relationships: disclosed no relevant relationships.

Figures

None
Graphical abstract
Diagram of study cohort. AJCC = American Joint Committee on Cancer,
BCSC = Breast Cancer Surveillance Consortium, BI-RADS = Breast Imaging
Reporting and Data System, DBT = digital breast tomosynthesis, NOS = not
otherwise specified.
Figure 1:
Diagram of study cohort. AJCC = American Joint Committee on Cancer, BCSC = Breast Cancer Surveillance Consortium, BI-RADS = Breast Imaging Reporting and Data System, DBT = digital breast tomosynthesis, NOS = not otherwise specified.
Interval second breast cancer. Surveillance mammograms in a
43-year-old woman obtained 10 years after treatment of primary breast cancer
show negative results. A, Mediolateral oblique and, B, craniocaudal views
show postlumpectomy changes in the upper inner quadrant. C, Mediolateral
oblique and, D, craniocaudal views from diagnostic mammography performed 10
months later show a round mass with indistinct margins in the upper outer
quadrant, deep to a triangular skin marker indicating a new palpable lump. A
high-grade invasive ductal carcinoma with triple-negative receptor status
was subsequently diagnosed in this location.
Figure 2:
Interval second breast cancer. Surveillance mammograms in a 43-year-old woman obtained 10 years after treatment of primary breast cancer show negative results. A, Mediolateral oblique and, B, craniocaudal views show postlumpectomy changes in the upper inner quadrant. C, Mediolateral oblique and, D, craniocaudal views from diagnostic mammography performed 10 months later show a round mass with indistinct margins in the upper outer quadrant, deep to a triangular skin marker indicating a new palpable lump. A high-grade invasive ductal carcinoma with triple-negative receptor status was subsequently diagnosed in this location.

Comment in

References

    1. Buist DS , Abraham LA , Barlow WE , et al. . Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer . Breast Cancer Res Treat 2010. ; 124 ( 3 ): 863 – 873 . - PMC - PubMed
    1. Mannu GS , Wang Z , Broggio J , et al. . Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study . BMJ 2020. ; 369 m1570 . - PMC - PubMed
    1. Houssami N , Ciatto S . Mammographic surveillance in women with a personal history of breast cancer: how accurate? How effective? . Breast 2010. ; 19 ( 6 ): 439 – 445 . - PubMed
    1. Lu W , Schaapveld M , Jansen L , et al. . The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer . Eur J Cancer 2009. ; 45 ( 17 ): 3000 – 3007 . - PubMed
    1. Lu WL , Jansen L , Post WJ , Bonnema J , Van de Velde JC , De Bock GH . Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis . Breast Cancer Res Treat 2009. ; 114 ( 3 ): 403 – 412 . - PubMed

Publication types